The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Mar. 02, 2021
Filed:
Jun. 15, 2016
Applicant:
Nmd Pharma A/s, Århus N, DK;
Inventors:
Thomas Holm Pedersen, Risskov, DK;
Martin Broch-Lips, Skødstrup, DK;
Claus Elsborg Olesen, Åbyhøj, DK;
Marc Labelle, Bedford, NH (US);
Ole Bækgaard Nielsen, Egâ, DK;
Assignee:
NMD PHARMA A/S, Århus N, DK;
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 31/216 (2006.01); A61K 31/192 (2006.01); A61K 31/44 (2006.01); C07C 59/135 (2006.01); C07C 229/18 (2006.01); C07C 229/22 (2006.01); C07C 233/48 (2006.01); C07C 311/06 (2006.01); C07C 323/52 (2006.01);
U.S. Cl.
CPC ...
C07C 59/135 (2013.01); A61K 31/192 (2013.01); A61K 31/216 (2013.01); A61K 31/44 (2013.01); C07C 229/18 (2013.01); C07C 229/22 (2013.01); C07C 233/48 (2013.01); C07C 311/06 (2013.01); C07C 323/52 (2013.01); C07C 2601/02 (2017.05); C07C 2601/04 (2017.05); Y02A 50/30 (2018.01);
Abstract
The present invention relates to compositions comprising compounds for use in treating, ameliorating and/or preventing neuromuscular disorders. The compounds as defined herein preferably inhibit the ClC-1 ion channel. The invention further relates to methods of treating, preventing and/or ameliorating neuromuscular disorders, by administering said composition to a person in need thereof.